Skip to content

Comparison Of Autogenic Drainage & Active Cycle Of Breathing Techniques In Patients With Pneumonia

Comparison Of Autogenic Drainage & Active Cycle Of Breathing Techniques In Patients With Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220111053693N1
Enrollment
16
Registered
2022-01-21
Start date
2021-06-05
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia is inflammation of the lungs and fluid collection in the alveoli. The two most common organisms responsible for pneumonia in low-income countries are Streptococcus pneumoniae and Haemophilus influenzae . Children with pneumonia are treated with antibiotics, with hospitalisation and oxygen supplementation required in some cases, depending on disease severity. Accumulation of secretions in the airways due to respiratory infection contributes to the worsening of clinical symptoms and lead

Interventions

Intervention 1: In this study the sample size is 16, and is divided into 2 groups. Intervention group 1 and interventional group 2. Each group contain 8 individuals. Interventional group 1 will receiv

Sponsors

Riphah International University , Lahore, Pakistan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 35- 60 years. PNEUMONIA SEVERITY INDEX (PORT SCORE) CLASS I TO III Moderate to severe Grades for Severity of a Pulmonary Function Test Abnormality

Exclusion criteria

Exclusion criteria: Patients with secondary pneumonia-that is, as a complication of dysfunction of respiratory muscles, Chronic bronchitis, Emphysema, Asthma Patients with known pulmonary tuberculosis or lung cancer. Intellectually impaired

Design outcomes

Primary

MeasureTime frame
Forced Vital Capacity (FVC). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The pulmonary function variables which will be assessed would be the Forced Vital Capacity (FVC) with the use of a spirometer. A brief description about the assessment procedure including technical steps to obtain pulmonary function data and variables will be explained to each subject. After 2–3 tidal breaths, subjects will be asked to inhale deeply to total lung capacity and then immediately exhale rapidly (without any pause) through a disposable mouthpiece until as much air as possible has been expelled from the lungs. The test will be performed with each subject in in high sitting position. The assessment will be repeated 3 times after adequate rest. The average values of the forced vital capacity (FVC) will be recorded.;Forced Expiratory Volume in one second (FEV1). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The pulmonary function variables which will be assessed would be the Forced Expiratory Volume in one second (FEV1) with the use of a spirometer. A brief description about the assessment procedure including technical steps to obtain pulmonary function data and variables will be explained to each subject. After 2–3 tidal breaths, subjects will be asked to inhale deeply to total lung capacity and then immediately exhale rapidly (without any pause) through a disposable mouthpiece until as much air as possible has been expelled from the lungs. The test will be performed with each subject in in high sitting position. The assessment will be repeated 3 times after adequate rest. The average values of forced expiratory volume in the first second (FEV1) will be recorded.

Secondary

MeasureTime frame
The oxygen hemoglobin saturation (SpO2). Timepoint: Measurements will be repeated after 4 weeks of 1st intervention. Method of measurement: The oxygen hemoglobin saturation (SpO2) will be assessed using a non-invasive pulse oximeter.

Countries

Pakistan

Contacts

Public ContactAzed Ahsaan

Riphah international university lahore

azedahsaan786@gmail.com+92 335 6055553

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026